HIV-HBV coinfected patients have higher rates of liver-related morbidity, hospitalizations, and mortality compared to HBV or HIV mono-infected ones. Clinical studies have shown an accelerated progression of liver fibrosis and an increased incidence of HCC, resulting from the combined action of HBV replication, immune-mediated hepatocytolysis, and HIV-induced immunosuppression and immunosenescence. Antiviral therapy based on dually active antiretrovirals is highly efficient, but late initiation, global disparities in accessibility, suboptimal regimens, and adherence issues may limit its impact on the development of end-stage liver disease. In this paper, we review the mechanisms of liver injuries in HIV-HBV coinfected patients and the novel biomarkers that can be used for treatment monitoring in HIV-HBV coinfected persons: markers that assess viral suppression, markers for liver fibrosis evaluation, and predictors of oncogenesis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10215721 | PMC |
| http://dx.doi.org/10.3390/biomedicines11051306 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Patterns of liver fibrosis evolution in Chinese HIV/HBV co-infected adults following 5-year antiretroviral treatment: a longitudinal study using non-invasive APRI and Fib-4 scores.
Virol Sin
December 2024
School of Public Health (Shenzhen), Sun Yat-sen University, Guangzhou, 510080, China; School of Public Health (Shenzhen), Shenzhen Campus of Sun Yat-sen University, Shenzhen, 518107, China. Electronic address:
The long-term effects of combined antiretroviral therapy (ART) on liver fibrosis patterns in adults living with HIV and chronic hepatitis B virus (HBV) are not well understood. Therefore, this study aimed to investigate the trajectories of liver fibrosis and identify the associations of baseline variables with different patterns of liver fibrosis evolution. A total of 333 individuals with HIV/HBV co-infection and undergoing long-term ART were enrolled in this study.
View Article and Find Full Text PDFPrevalence of HIV, HBV, and HCV infections and high-risk behaviors among women referred to drop-in centers in Lorestan Province, western Iran.
Arch Razi Inst
June 2024
Hepatitis Research Center, Department of Virology, School of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are known as the most common blood-borne viral infections worldwide. Individuals referring to drop-in centers (DICs) are considered high-risk people exposed to infection with blood-borne viruses. The purpose of this study was to investigate the prevalence of HIV, HBV, and HCV infections among women referred to DICs in Lorestan Province, western Iran.
View Article and Find Full Text PDFPrevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.
Viruses
October 2024
Department of Public Health, Universitas Padjadjaran, Bandung 40161, Indonesia.
Article Synopsis
- The World Health Organization advises hepatitis D virus (HDV) screening for those infected with hepatitis B virus (HBV), especially in resource-limited areas like Nigeria, due to HDV's serious health risks, including rapid liver disease progression.
- A systematic review using PRISMA guidelines analyzed 11 studies from 2009-2024, focusing on HDV prevalence, risk factors, and clinical outcomes in Nigeria, specifically looking at studies that employed IgG antibody testing or RNA diagnostics.
- The findings revealed HDV prevalence among HBV patients in Nigeria varied widely from 2.0% to 31.6%, with the highest rates in the Southwest among malaria patients, and a notable increase in prevalence among young males aged
Article Synopsis
- - This case report details an unusual instance of acute kidney injury (AKI) along with nephrotic syndrome in a Pacific Islander who also had acute HIV and hepatitis B virus (HBV) coinfections, ultimately requiring hemodialysis.
- - The patient fully recovered and ceased dialysis after receiving high-dose steroids and antiviral treatment, with the renal biopsy showing signs of both HIV-associated and HBV-associated nephropathy, as well as significant CD8 lymphocyte infiltration.
- - The report underscores management challenges, particularly regarding the decision to start antiviral treatment alongside immunosuppressive therapy, and notes that combined nephropathy in HIV-HBV co-infection is extremely rare and has not been previously reported.
Skin cancer in patients who are co-infected with HIV/ HBV or HIV/HCV: a systematic review.
Arch Dermatol Res
November 2024
Department of Dermatology, SUNY Downstate, 450 Clarkson Ave, Brooklyn, NY, USA.
Skin cancer, the most common cancer in the United States, has been well-described in the literature to be associated with environmental factors including ultraviolet (UV) radiation. However, the effect of chronic viral infections on risk of skin cancer development, particularly in individuals co-infected with Human Immunodeficiency Virus (HIV) and Hepatitis B or C Viruses (HBV/HCV), has yet to be elucidated. This systematic review aims to be one of the first to consolidate existing literature and examine the relationship between skin cancer and HIV/HBV and HIV/HCV co-infections.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!